Joshua Schiff, MD

Title(s)Assistant Professor of Clinical Radiation Oncology
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Washington University School of Medicine in St. Louis, St. Louis, MO06/2024Residency - Radiation Oncology
    Cedars Sinai Medical Center, Los Angeles, CA06/2020Internship - Internal Medicine
    Tulane University School of Medicine, New Orleans, LAMD05/2019
    University of California, Santa Barbara, Santa Barbara, CABS06/2014

    Collapse Overview 
    Collapse Overview
    Dr. Joshua P. Schiff is an Assistant Professor of Clinical Radiation Oncology at the Keck School of Medicine. He joined the faculty in the fall of 2024. His clinical practice is currently primarily at the Norris Comprehensive Cancer Center.

    He grew up in Los Angeles in the San Fernando Valley, and graduated from the University of California, Santa Barbara with a bachelor’s degree in Biopsychology. He earned his medical doctorate degree at the Tulane University School of Medicine, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed his residency at the Washington University School of Medicine in St. Louis, where he was chief resident.

    Dr. Schiff specializes in the treatment of a variety of cancer types using advanced radiotherapy delivery methods. He has extensive experience with modern treatment techniques including intensity-modulated radiation therapy, volumetric-modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and motion management techniques. He has obtained funding for and opened multiple clinical trials with a focus on the implementation of new technology to improve treatment outcomes for patients, having previously focused on online adaptive radiotherapy, and now focusing on biology-guided radiotherapy. His work has resulted in numerous publications, presentations at national meetings, and awards, including the Roentgen Resident/Fellow Research award from the Radiological Society of North America.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma. Radiother Oncol. 2024 Aug 11; 200:110473. D'Souza A, Stowe HB, Green OL, Schiff J, Hugo GD, Ginn J, Maraghechi B, Kang KH, Kim H, Badiyan SN, Samson P, Robinson CG, Price A, Henke LE. PMID: 39137832.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    2. Cone-Beam Computed Tomography (CBCT)-Guided Adaptive Boost Radiotherapy for a Patient With Locally Advanced Cervical Cancer Ineligible for Brachytherapy. Cureus. 2024 Aug; 16(8):e66218. Silberstein AE, Schiff JP, Beckert R, Zhao X, Laugeman E, Markovina S, Contreras JA. PMID: 39233928; PMCID: PMC11374352.
      View in: PubMed   Mentions:
    3. Feasibility of simulation free abdominal stereotactic adaptive radiotherapy using an expedited pre-plan workflow. Phys Imaging Radiat Oncol. 2024 Jul; 31:100611. Price AT, Schiff JP, Silberstein A, Beckert R, Zhao T, Hugo GD, Samson PP, Laugeman E, Henke LE. PMID: 39253730; PMCID: PMC11382001.
      View in: PubMed   Mentions:
    4. The First Reported Case of Treating the Ultra-Central Thorax With Cone Beam Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR). Cureus. 2024 Jun; 16(6):e62906. Zhao S, Beckert R, Zhao X, Laugeman E, Robinson CG, Vlacich G, Samson PP, Schiff JP. PMID: 39040774; PMCID: PMC11262774.
      View in: PubMed   Mentions: 1  
    5. The impact of an Advanced Practice Radiation Therapist contouring for a CBCT-based adaptive radiotherapy program. Tech Innov Patient Support Radiat Oncol. 2024 Jun; 30:100242. Beckert R, Schiff JP, Morris E, Samson P, Kim H, Laugeman E. PMID: 38495830; PMCID: PMC10940769.
      View in: PubMed   Mentions: 1  
    6. Feasibility of surface-guidance combined with CBCT for intra-fractional breath-hold motion management during Ethos RT. J Appl Clin Med Phys. 2024 Apr; 25(4):e14242. Kim T, Laugeman E, Kiser K, Schiff J, Marasini S, Price A, Gach HM, Knutson N, Samson P, Robinson C, Hatscher C, Henke L. PMID: 38178622; PMCID: PMC11005966.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    7. The Use of MR-Guided Radiation Therapy for Liver Cancer. Semin Radiat Oncol. 2024 01; 34(1):36-44. Prime S, Schiff JP, Hosni A, Stanescu T, Dawson LA, Henke LE. PMID: 38105091.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry. Clin Transl Radiat Oncol. 2024 Jan; 44:100692. Kiser K, Schiff J, Laugeman E, Kim T, Green O, Hatscher C, Kim H, Badiyan S, Spraker M, Samson P, Robinson C, Price A, Henke L. PMID: 38021090; PMCID: PMC10652138.
      View in: PubMed   Mentions: 4  
    9. Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program. Clin Transl Radiat Oncol. 2023 Sep; 42:100661. Price AT, Schiff JP, Laugeman E, Maraghechi B, Schmidt M, Zhu T, Reynoso F, Hao Y, Kim T, Morris E, Zhao X, Hugo GD, Vlacich G, DeSelm CJ, Samson PP, Baumann BC, Badiyan SN, Robinson CG, Kim H, Henke LE. PMID: 37529627; PMCID: PMC10388162.
      View in: PubMed   Mentions: 1  
    10. Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience. Clin Transl Radiat Oncol. 2023 Jul; 41:100627. Chin RI, Schiff JP, Bommireddy A, Kang KH, Andruska N, Price AT, Green OL, Huang Y, Korenblat K, Parikh PJ, Olsen J, Samson PP, Henke LE, Kim H, Badiyan SN. PMID: 37441543; PMCID: PMC10334127.
      View in: PubMed   Mentions: 2  
    11. Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease. Adv Radiat Oncol. 2023 Nov-Dec; 8(6):101226. Schiff JP, Laugeman E, Stowe HB, Zhao X, Hilliard J, Hawk E, Watkins J, Hatscher C, Badiyan SN, Samson PP, Hugo GD, Robinson CG, Price AT, Henke LE. PMID: 37206996; PMCID: PMC10188549.
      View in: PubMed   Mentions: 4  
    12. Knowledge-based adaptive planning quality assurance using dosimetric indicators for stereotactic adaptive radiotherapy for pancreatic cancer. Radiother Oncol. 2023 05; 182:109603. Forghani F, Ginn JS, Schiff JP, Zhu T, Marut L, Laugeman E, Maraghechi B, Badiyan SN, Samson PP, Kim H, Robinson CG, Hugo GD, Henke LE, Price AT. PMID: 36889595.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer. Dis Colon Rectum. 2023 07 01; 66(7):973-982. Chin RI, Schiff JP, Shetty AS, Pedersen KS, Aranha O, Huang Y, Hunt SR, Glasgow SC, Tan BR, Wise PE, Silviera ML, Smith RK, Suresh R, Byrnes K, Samson PP, Badiyan SN, Henke LE, Mutch MG, Kim H. PMID: 36876988.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Ablative radiotherapy for colorectal liver metastases and intrahepatic cholangiocarcinoma. Surgery. 2023 07; 174(1):108-112. Schiff JP, D'Souza A, Henke LE. PMID: 36870808.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. First treatments for Lattice stereotactic body radiation therapy using magnetic resonance image guided radiation therapy. Clin Transl Radiat Oncol. 2023 Mar; 39:100577. Price AT, Schiff JP, Zhu T, Mazur T, Kavanaugh JA, Maraghechi B, Green O, Kim H, Spraker MB, Henke LE. PMID: 36718251; PMCID: PMC9883196.
      View in: PubMed   Mentions: 1  
    16. A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT). Clin Transl Radiat Oncol. 2023 Mar; 39:100561. Schiff JP, Maraghechi B, Chin RI, Price A, Laugeman E, Rudra S, Hatscher C, Spraker MB, Badiyan SN, Henke LE, Green O, Kim H. PMID: 36594078; PMCID: PMC9803918.
      View in: PubMed   Mentions: 5  
    17. Simulation-Free Radiation Therapy: An Emerging Form of Treatment Planning to Expedite Plan Generation for Patients Receiving Palliative Radiation Therapy. Adv Radiat Oncol. 2023 Jan-Feb; 8(1):101091. Schiff JP, Zhao T, Huang Y, Sun B, Hugo GD, Spraker MB, Abraham CD. PMID: 36304132; PMCID: PMC9594122.
      View in: PubMed   Mentions: 9  
    18. An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331). Adv Radiat Oncol. 2023 Jan-Feb; 8(1):101083. Schiff JP, Lee Y, Wang Y, Perkins SM, Kessel SK, Fitzgerald TJ, Larrier NA, Michalski JM. PMID: 36483060; PMCID: PMC9723303.
      View in: PubMed   Mentions: 1  
    19. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR). Radiat Oncol. 2022 Sep 13; 17(1):157. Kim M, Schiff JP, Price A, Laugeman E, Samson PP, Kim H, Badiyan SN, Henke LE. PMID: 36100866; PMCID: PMC9472353.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    20. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Radiother Oncol. 2022 10; 175:144-151. Schiff JP, Price AT, Stowe HB, Laugeman E, Chin RI, Hatscher C, Pryser E, Cai B, Hugo GD, Kim H, Badiyan SN, Robinson CG, Henke LE. PMID: 36063981.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    21. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases. Int J Radiat Oncol Biol Phys. 2022 12 01; 114(5):1022-1031. Schiff JP, Stowe HB, Price A, Laugeman E, Hatscher C, Hugo GD, Badiyan SN, Kim H, Robinson CG, Henke LE. PMID: 35768023.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    22. Overall survival in patients with FIGO stage IVA cervical cancer. Gynecol Oncol. 2022 08; 166(2):292-299. Schiff JP, Mintz R, Cohen AC, Huang Y, Thaker P, Massad LS, Powell M, Mutch D, Schwarz JK, Markovina ST, Grigsby PW. PMID: 35691754.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Oligometastatic Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Chemotherapy With Nonoperative Intent of the Primary for Locoregional Complete Responders. Pract Radiat Oncol. 2022 Sep-Oct; 12(5):e406-e414. Schiff JP, Chin RI, Roy A, Mahapatra L, Stowe HB, Andruska N, Huang Y, Mutch M, Fields RC, Hawkins WG, Doyle M, Chapman W, Tan B, Henke LE, Badiyan SN, DeSelm C, Samson PP, Pedersen K, Kim H. PMID: 35526826.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies. Gynecol Oncol. 2022 06; 165(3):486-492. Schiff JP, Mahmood M, Huang Y, Powell MA, Mutch D, Dyk PT, Lin AJ, Schwarz JK, Markovina ST, Grigsby PW. PMID: 35370010.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy. Cancers (Basel). 2021 Oct 20; 13(21). Chin RI, Schiff JP, Brenneman RJ, Gay HA, Thorstad WL, Lin AJ. PMID: 34771432; PMCID: PMC8582444.
      View in: PubMed   Mentions: 1  
    26. Tumor Lysis Syndrome in a Patient With Metastatic Endometrial Cancer Treated With Lattice Stereotactic Body Radiation Therapy. Adv Radiat Oncol. 2022 Jan-Feb; 7(1):100797. Schiff JP, Spraker MB, Duriseti S, Shaikh S, Murad HF, Mutch DG, Robinson CG, Kavanaugh J, Lin AJ. PMID: 34761139; PMCID: PMC8567179.
      View in: PubMed   Mentions: 6  
    27. Technical Challenges of Heart Avoidance for Synchronous Breast and Lung Cancers in a Postmenopausal Female: A Planning Case Report From a Safety-Net Hospital. Adv Radiat Oncol. 2020 Sep-Oct; 5(5):1076-1082. Marques C, Schiff J, Momin F, McAllister N, Jennelle RL, Bian SX, Schechter NR, Yoo SK. PMID: 33083670; PMCID: PMC7557127.
      View in: PubMed   Mentions:
    28. Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer. BMC Cancer. 2019 May 31; 19(1):524. Schiff JP, Cotogno P, Feibus A, Steinwald P, Ledet E, Lewis B, Sartor O. PMID: 31151428; PMCID: PMC6544996.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    29. First Reported Case of Pediatric Radiation Treatment With Magnetic Resonance Image Guided Radiation Therapy. Adv Radiat Oncol. 2019 Apr-Jun; 4(2):233-236. Henke LE, Green OL, Schiff J, Rodriguez VL, Mutic S, Michalski J, Perkins SM. PMID: 31011667; PMCID: PMC6460231.
      View in: PubMed   Mentions: 9  
    30. Prostate-specific Antigen Response and Eradication of Androgen Receptor Amplification with High-dose Testosterone in Prostate Cancer. Eur Urol. 2017 06; 71(6):997-998. Schiff JP, Lewis BE, Ledet EM, Sartor O. PMID: 28040353.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Joshua's Networks
    Concepts (61)
    Derived automatically from this person's publications.
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _